1. Home
  2. IKNA vs OPHC Comparison

IKNA vs OPHC Comparison

Compare IKNA & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • OPHC
  • Stock Information
  • Founded
  • IKNA 2016
  • OPHC 2000
  • Country
  • IKNA United States
  • OPHC United States
  • Employees
  • IKNA N/A
  • OPHC N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • OPHC Major Banks
  • Sector
  • IKNA Health Care
  • OPHC Finance
  • Exchange
  • IKNA Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • IKNA 61.8M
  • OPHC 51.8M
  • IPO Year
  • IKNA 2021
  • OPHC N/A
  • Fundamental
  • Price
  • IKNA $1.35
  • OPHC $4.50
  • Analyst Decision
  • IKNA Strong Buy
  • OPHC
  • Analyst Count
  • IKNA 1
  • OPHC 0
  • Target Price
  • IKNA $4.00
  • OPHC N/A
  • AVG Volume (30 Days)
  • IKNA 79.7K
  • OPHC 8.7K
  • Earning Date
  • IKNA 08-07-2025
  • OPHC 08-05-2025
  • Dividend Yield
  • IKNA N/A
  • OPHC N/A
  • EPS Growth
  • IKNA N/A
  • OPHC 30.24
  • EPS
  • IKNA N/A
  • OPHC 1.33
  • Revenue
  • IKNA N/A
  • OPHC $39,980,000.00
  • Revenue This Year
  • IKNA N/A
  • OPHC N/A
  • Revenue Next Year
  • IKNA N/A
  • OPHC N/A
  • P/E Ratio
  • IKNA N/A
  • OPHC $3.39
  • Revenue Growth
  • IKNA N/A
  • OPHC 53.28
  • 52 Week Low
  • IKNA $0.97
  • OPHC $3.53
  • 52 Week High
  • IKNA $1.94
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 53.36
  • OPHC 56.69
  • Support Level
  • IKNA $1.31
  • OPHC $4.36
  • Resistance Level
  • IKNA $1.38
  • OPHC $4.46
  • Average True Range (ATR)
  • IKNA 0.06
  • OPHC 0.06
  • MACD
  • IKNA -0.01
  • OPHC -0.00
  • Stochastic Oscillator
  • IKNA 15.79
  • OPHC 62.50

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: